Delivery of AAV-hAADC to rats with pre-existing immunity to AAV

被引：0
|
作者：
Sanftner, L [1 ]
Suzuki, B [1 ]
Doroudchi, M [1 ]
Feng, L [1 ]
McClelland, A [1 ]
Forsayeth, J [1 ]
Cunningham, J [1 ]
机构：
[1] Avigen Inc, Alameda, CA USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
228
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV
    Sanftner, LM
    Suzuki, BM
    Doroudchi, MM
    Feng, L
    McClelland, A
    Forsayeth, JR
    Cunningham, J
    MOLECULAR THERAPY, 2004, 9 (03) : 403 - 409
  • [2] Characterization of Pre-Existing Immunity to AAV5
    Lau, Kelly
    MOLECULAR THERAPY, 2023, 31 (04) : 515 - 515
  • [3] Strategy to detect pre-existing immunity to AAV gene therapy
    Falese, L.
    Sandza, K.
    Yates, B.
    Triffault, S.
    Gangar, S.
    Long, B.
    Tsuruda, L.
    Carter, B.
    Vettermann, C.
    Zoog, S. J.
    Fong, S.
    GENE THERAPY, 2017, 24 (12) : 768 - 778
  • [4] A Novel Strategy to Circumvent Pre-Existing Humoral Immunity to AAV
    Mingozzi, Federico
    Anguela, Xavier M.
    Pavani, Giulia
    Chen, Yifeng
    Davidson, Robert J.
    Hui, Daniel J.
    Hinderer, Christian J.
    Faella, Armida
    Howard, Crolann
    Tai, Alex
    Podsakoff, Gregory M.
    Ragni, Margaret V.
    Zhou, Shangzhen
    Basner-Tschakarjan, Etiena
    Wright, J. Fraser
    High, Katherine A.
    BLOOD, 2012, 120 (21)
  • [5] Strategy to detect pre-existing immunity to AAV gene therapy
    L Falese
    K Sandza
    B Yates
    S Triffault
    S Gangar
    B Long
    L Tsuruda
    B Carter
    C Vettermann
    S J Zoog
    S Fong
    Gene Therapy, 2017, 24 : 768 - 778
  • [6] Prevalence of pre-existing immunity to AAV8 and other AAV serotypes in healthy individuals
    Kruzik, A.
    Fetahagic, D.
    Hartlieb, B.
    Horling, F. M.
    Scheiflinger, F.
    Reipert, B. M.
    de la Rosa, M.
    HUMAN GENE THERAPY, 2017, 28 (12) : A21 - A22
  • [7] Pre-existing immunity to AAV overcome by in silico ancestral capsid design
    Zinn, E.
    Khaychuk, V.
    Sarkar, D.
    Carvalho, L.
    Pacouret, S.
    Morris, H.
    Plovie, E.
    Vandenberghe, Luk H.
    HUMAN GENE THERAPY, 2014, 25 (11) : A8 - A8
  • [8] Overcoming Pre-Existing Humoral Immunity to AAV Using Capsid Decoys
    Mingozzi, Federico
    Anguela, Xavier M.
    Pavani, Giulia
    Chen, Yifeng
    Davidson, Robert H.
    Hui, Daniel H.
    Yazicioglu, Mustafa
    Elkouby, Liron
    Hinderer, Christian J.
    Faella, Armida
    Howard, Carolann
    Tai, Alex
    Podsakoff, Gregory M.
    Ragni, Margaret C.
    Zhou, Shangzhen
    Basner-Tschakarjan, Etiena
    Wright, J. Fraser
    High, Katherine A.
    MOLECULAR THERAPY, 2013, 21 : S45 - S45
  • [9] Transient depletion of pre-existing antibodies for efficient AAV gene delivery
    Fu, Haiyan
    Samowitz, Preston
    Forsberg, John
    Feng, Richard
    Nicely, Nathan
    Bobo, Tierra
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S44 - S44
  • [10] Engineering AAV Capsid Variants to Overcome Pre-Existing Immunity and Improve Gene Delivery to Human Liver
    Feiner, Rebecca
    Hill, Jake
    Pilla, Dario
    Aungier, Juliet
    Ravi, Sujata
    Allen, Olivia
    Shehu, Erald
    Horer, Markus
    Dane, Allison
    MOLECULAR THERAPY, 2022, 30 (04) : 65 - 65
12345